Literature DB >> 33539997

Exploration and evaluation of dynamic dose-control platform for pediatric medicine based on Drop-on-Powder 3D printing technology.

Mengsuo Cui1, Hao Pan2, Dongyang Fang1, Haowei Sun3, Sen Qiao1, Weisan Pan4.   

Abstract

Patient responses to doses vary widely, and affording limited doses to such a diverse population will inevitably yield unsatisfactory therapeutic effects and even adverse effects. In Particular, there is an urgent demand for a dynamic dose-control platform for pediatric patients, many of whom require diverse doses and flexible dose adjustments. The aim of this study was to explore the possibility of using a drop-on-powder (DoP) technology-based desktop 3D printer to build a dynamic dose-control platform for theophylline (TP) and metoprolol tartrate (MT). In addition, the impact of drug loading patterns on the accuracy of dose regulation was also assessed. All of the printed tablets exhibited good mechanical properties and satisfactory structural integrity. On printing tablets with target drug doses, the accuracy was in the range of 91.2~108% with a small variation coefficient in the range of 0.5~3.2%. Compared with traditional divided-dose methods, drop-on-powder 3D printing technology exhibited higher accuracy in dose regulation, but had less impact on the in vitro drug release behavior. The results in this work clearly indicate the possibility and ability of DoP technology as a promising method for constructing a dynamic dose-control platform for the fabrication of personalized medicines for pediatric patients.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drop-on-powder 3D printing technology (DoP); Dynamic dose-control platform; Metoprolol tartrate (MT); Pediatric patient; Personalized medicines; Theophylline (TP)

Mesh:

Substances:

Year:  2021        PMID: 33539997     DOI: 10.1016/j.ijpharm.2021.120201

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

Review 1.  3D Printing of Pediatric Medication: The End of Bad Tasting Oral Liquids?-A Scoping Review.

Authors:  Iris Lafeber; Elisabeth J Ruijgrok; Henk-Jan Guchelaar; Kirsten J M Schimmel
Journal:  Pharmaceutics       Date:  2022-02-14       Impact factor: 6.321

Review 2.  The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing?

Authors:  Ioannis I Andreadis; Christos I Gioumouxouzis; Georgios K Eleftheriadis; Dimitrios G Fatouros
Journal:  Pharmaceutics       Date:  2022-03-10       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.